睾酮治疗中的跨男性个体子宫病理:一项回顾性多中心病例系列
这项回顾性多中心病例系列回顾了94例接受睾酮后行子宫切除术的跨男性个体的子宫病理报告,平均年龄30±8.6岁,从起始睾酮至子宫切除术的平均间隔为36.7±36.6个月。大多数患者(n=65;69.1%)存在活动性子宫内膜,1例为不伴异型性的复杂增生,无子宫内膜癌病例。作者鼓励对该人群的异常子宫出血进行个体化咨询。
要点
- 94例接受睾酮后行子宫切除术的跨男性个体中,活动性子宫内膜占69.1%(n=65)。
- 1例为不伴异型性的复杂增生,无子宫内膜癌病例。
- 尽管多数跨男性个体在睾酮治疗下闭经,组织病理学上子宫内膜活动持续存在,以增殖期子宫内膜为主。
核心结论
- 尽管多数接受睾酮的跨男性个体闭经,但组织病理学上子宫内膜活动持续存在,以增殖期子宫内膜为主。
- 作者鼓励对该人群的异常子宫出血进行个体化咨询。
研究设计与样本
- 回顾性多中心病例系列,审查接受睾酮后行子宫切除术的跨男性个体的子宫病理报告,共94例符合搜索标准。
主要发现
- 平均年龄30±8.6岁,从起始睾酮至子宫切除术的平均间隔为36.7±36.6个月。
- 活动性子宫内膜见于多数患者(n=65;69.1%)。
- 1例为不伴异型性的复杂增生,无子宫内膜癌病例。
临床怎么用
- 作者鼓励对该人群的异常子宫出血进行个体化咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As part of transition, transmasculine persons often use testosterone gender-affirming hormone therapy; however, there is limited data on its long-term effects. The impact of exogenous testosterone on uterine pathology remains unclear. While testosterone achieves amenorrhea in the majority of this population, persistence of abnormal uterine bleeding can be difficult to manage. Excess androgens in cisgender females are associated with pathologic uterine processes such as polycystic ovary syndrome, endometrial hyperplasia, or cancer. There are no guidelines for management of abnormal uterine bleeding or endometrial surveillance in this population. OBJECTIVE: The aim of this study was to describe the characteristics of uterine pathology after the initiation of testosterone in transmasculine persons. MATERIALS AND METHODS: A retrospective, multicenter case series was performed. Uterine pathology reports of transmasculine persons who received testosterone and subsequently underwent hysterectomy were reviewed. The endometrial phase and endometrial thickness were recorded. RESULTS: A total of 94 subjects met search criteria. The mean age of participants was 30 ± 8.6 years, and the mean interval from initiation of testosterone to hysterectomy was 36.7 ± 36.6 months. Active endometrium was found in the majority of patients (n = 65; 69.1%). One patient had complex hyperplasia without atypia. There were no cases of endometrial cancer. CONCLUSION: Despite amenorrhea in the majority of transmasculine persons on testosterone, endometrial activity persists with predominantly proliferative endometrium on histopathology. Individualized counseling for abnormal uterine bleeding is encouraged in this patient population.
引用
- Grimstad FW, Fowler KG, New EP, et al. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series. Am J Obstet Gynecol. 2018. PMID: 30579875. doi:10.1016/j.ajog.2018.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。